Moderna's new COVID vaccine, mNEXSPIKE, has quickly become its leading product in the U.S. retail channel since its launch in Q3 2025. This rapid commercial success creates pressure to optimize supply chain, distribution, and marketing analytics to maintain market share and support continued growth.
Filing excerpt
We currently have three commercial products - Spikevax and mNEXSPIKE (our COVID vaccines) and mRESVIA (our vaccine against respiratory syncytial virus (RSV)).
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-10kproductLaunchGet every 10-K signal for Moderna and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Moderna this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/5dccbcf7-2e32-4f1b-934a-0fd10d398808 returns this record as JSON. POST /v1/companies/enrich returns every signal for modernatx.com.
{
"signal_id": "5dccbcf7-2e32-4f1b-934a-0fd10d398808",
"signal_type": "sec-10k",
"signal_subtype": "productLaunch",
"detected_at": "2026-02-24T09:33:59.024+00:00",
"company": {
"name": "Moderna",
"domain": "modernatx.com"
},
"data": {
"detail": "Moderna's new COVID vaccine, mNEXSPIKE, has quickly become its leading product in the U.S. retail channel since its launch in Q3 2025. This rapid commercial success creates pressure to optimize supply chain, distribution, and marketing analytics to maintain market share and support continued growth.",
"metrics": {
"timeframe": "current_year"
},
"summary": "New COVID vaccine mNEXSPIKE launched in Q3 2025, now leading US retail product",
"excerpts": "We currently have three commercial products - Spikevax and mNEXSPIKE (our COVID vaccines) and mRESVIA (our vaccine against respiratory syncytial virus (RSV)).",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285226000033/mrna-20251231.htm",
"filing_date": "2026-02-20",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Go-to-market support",
"signal_category": "strategic",
"regions_mentioned": [
"U.S."
]
}
}
curl https://signals.autobound.ai/v1/signals/5dccbcf7-2e32-4f1b-934a-0fd10d398808 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"modernatx.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.